Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2001

View Archived Issues

Recombinant hGH approved in E.U. for Turner's syndrome

BioMarin exercises option to product candidate for burns and wounds

Phogen and Atugen combine technologies in new alliance

Medarex and B. Twelve to develop human antibody therapeutics for cancer

Cellegy accelerates U.S. filing for Anogesic

Two new antiasthmatic compounds included in Inflazyme/Aventis alliance

Grant for paraoxonase research awarded to U. Michigan and Esperion

Binding and functional activity of the first truly selective alpha1A antagonist characterized

Scotia's Foscan receives negative opinion from EMEA

Roche highlights recent achievements in Japan

Dutch group identifies novel classes of adenosine receptor antagonists

Phytera achieves research milestone in antifungal drug collaboration with Lilly

Herbal remedy as a therapeutic option in premenstrual syndrome

Alista enters phase II evaluation for FSD

Second milestone achieved in Cubist/Novartis antiinfective alliance

NicOx's HCT-3012 moves into phase II clinical trials in Europe and the U.S.

Molecular mechanisms of antidiabetic and antiobesity effects of AJ-9677

Pexelizumab has a significant impact on outcome of CABG patients in phase II

CeNeS to market Xefo in the U.K.; product launch planned for 2001

Chemokine receptor antagonists designed at the former SmithKline Beecham

Antimalarial agents with a 2,3-dioxabicyclo[3.3.1]nonane structure

Sagami patents new series of immunosuppressants acting on protein phosphatase

Nymox and Biophage establish collaborative agreement for antimicrobial treatments

Inhibitors of PDE4 with antiasthmatic effects identified at Fuji Photo Film

Recent Japanese patent covers naturally occurring antiinflammatory agents

N-type calcium channel blockers and their use claimed in recent patent

New antibacterial peptide discovered at Meiji Milk Products

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...